BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9192124)

  • 1. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
    Head A; Maxwell S; Kendall MJ
    Br J Sports Med; 1997 Jun; 31(2):120-5. PubMed ID: 9192124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
    Head A; Maxwell S; Kendall MJ; Eagles C
    Br J Clin Pharmacol; 1994 Dec; 38(6):499-504. PubMed ID: 7888287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    Eagles CJ; Kendall MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Submaximal, but not maximal, exercise testing detects differences in the effects of beta-blockers during treadmill exercise: a study of celiprolol and atenolol. II.
    McLenachan JM; Grant S; Ford I; Henderson E; Dargie HJ
    Am Heart J; 1991 Feb; 121(2 Pt 2):691-6. PubMed ID: 1671188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding beta-2 agonism does not improve beta-1 blockade exercise responses in hypertensives.
    Rueckert PA; Slane PR; Hanson P
    Med Sci Sports Exerc; 1994 Aug; 26(8):945-50. PubMed ID: 7968427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of celiprolol, a new beta 1-alpha 2 blocker, on the cardiovascular response to exercise.
    Caruso FS; Berger BM; Darragh A; Weng T; Vukovich R
    J Clin Pharmacol; 1986 Jan; 26(1):32-8. PubMed ID: 2869057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo controlled comparison of the effects of metoprolol and celiprolol on echo-Doppler measurements of cardiovascular function in normal volunteers.
    Silke B; Thompson A; Leitch A; Riddell JG
    Br J Clin Pharmacol; 1995 Jul; 40(1):37-42. PubMed ID: 8527266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta adrenergic blockade does not improve effort tolerance in patients with mitral stenosis in sinus rhythm.
    Patel JJ; Dyer RB; Mitha AS
    Eur Heart J; 1995 Sep; 16(9):1264-8. PubMed ID: 8582390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade. Comparison between a beta 1-selective and a non-selective beta blocker.
    Verstappen FT; van Baak MA
    Eur J Appl Physiol Occup Physiol; 1987; 56(6):712-8. PubMed ID: 2890520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ratings of perceived exertion for predicting maximal work rate and prescribing exercise intensity in patients taking atenolol.
    Eston RG; Thompson M
    Br J Sports Med; 1997 Jun; 31(2):114-9. PubMed ID: 9192123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ; Grant S; McLenachan J
    Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of celiprolol on cardiac hypertrophy in hypertension.
    Haneda T; Ogawa Y; Kato J; Matsuhashi H; Morimoto H; Honda H; Takenaka T; Tanazawa S; Kataoka R; Kikuchi K
    Hypertens Res; 2000 Sep; 23(5):467-74. PubMed ID: 11016801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.